Vimta Labs Ltd

NSE: VIMTALABS · BSE: 524394 · Healthcare · 28 announcements

Share price: ₹570.05
Market cap: ₹2,548 Cr
Revenue (annual): ₹407.3 Cr
Net profit (annual): ₹77.51 Cr
P/E (TTM): 32.0×Sector 53.1×
Promoter holding: 35.67%-0.18% QoQ
FII holding: 4.41%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 5 Financial Results 3 Employee Stock Options 3 Results Update 2 Other Announcement 2 Management Change 2 Dividend 2 Board Meeting Date 2 Annual General Meeting 2 Price Movement Clarification 1 Debt & Borrowing 1 Credit Rating 1 Annual Report 1 Adverse Business Impact 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

25 Jun 2026 22:40 IST NSE

Management Change

Vimta Labs Management Change

Vimta Labs re-appointed Sivalinga Prasad Vasireddi as Executive Director for five years. The change is effective from July 01, 2026.

Execution: 60 months

Read the filing ↗

6 May 2026 16:59 IST NSE

Management Change

Vimta Labs Management Change

Vimta Labs Limited has recommended the re-appointment of Dr. S. P. Vasireddi as Executive Chairman for a five-year term effective from July 1, 2026, to June 30, 2031. The appointment is subject to shareholder approval at the upcoming Annual General Meeting. Dr. Vasireddi is the company's founder with over four decades of experience.

Execution: 5 years

Read the filing ↗